SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a reported surge in revenue and a small float, sparking excitement about a potential massive run. The community is focused on the stock's low float and are watching for news catalysts, drawing comparisons to other stocks with similar setups. Some traders are also pointing to the stock's chart patterns as a reason for optimism.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss a potential short squeeze, noting high borrowing costs and a seemingly limited float. Community members are debating the impact of insider activity and monitoring short interest data. Some investors suggest a buy-and-hold strategy, while others point to technical indicators.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to discussions surrounding Amazon's competitive moves in the DSP space, sparking debates about market share and potential impacts. The community is analyzing Amazon's recent offer of head-to-head testing and ADWEEK's reporting of it. Investors are closely watching Trade Desk's response and its long-term strategies in a competitive landscape.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZ is trending as investors discuss its potential undervaluation relative to its Ethereum holdings, amplified by interest from meme stock communities and the disclosed stake of an activist investor. Community talking points revolve around its asset value, potential for a short squeeze given the low float, and comparison to other Ethereum treasury plays. However, concerns persist regarding potential dilution from convertible notes and the company's cash burn.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

Picard Medical (PMI) is trending amid significant stock volatility, prompting the company to release a statement clarifying they are unaware of any undisclosed material changes. The community is actively discussing potential dilution, short covering, and speculating about a possible pump and dump, while some remain bullish, citing the company's unique position in the artificial heart market.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as the community emphasizes its potential for profit, particularly its availability on Phantom Wallet. The conversation highlights a blend of 'ancient' and 'modern' gains, with users frequently mentioning fire and wisdom as key themes. The coin's association with other Solana tokens is also part of the discussion.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community actively discussing the potential market impact and likelihood of approval. While some express concerns about potential side effects and a history of sell-offs post-approval, others point to the drug's efficacy and the company's strong financial position, anticipating a significant upside if approved. Community members are closely monitoring discussions around analyst price targets, short interest, and potential buyout scenarios.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is experiencing significant volatility, with community members actively discussing a large pre-market surge following news of a strategic partnership. The conversation includes speculation about a short squeeze, potential for further gains, and caution due to the stock's history of volatile price action and possible pump and dump schemes. Some traders are taking profits while others are holding in anticipation of after-hours movement.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is trending as community members discuss its potential and setbacks, with some pointing to a recent FDA approval for Uzedy as a positive catalyst. Despite some positive news, negative sentiment persists regarding the stock's performance and leadership. Analysts are weighing in, with price target adjustments and discussions around the company's "Pivot to Growth" strategy.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid community discussion around a recent FDA investigation into allergic reactions linked to specific lots of intravenous immune globulin (IVIG) drugs, including two ADMA products; although these reactions are acknowledged as rare, the news has sparked concerns and trading volatility. Some investors view the dip as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run, while others express frustration with the stock's recent performance and management's silence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sirius XM (SIRI) Reports Next Week: Wall Street Expects Earnings Growth

Sirius XM (SIRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SiriusXM Declares Quarterly Cash Dividend

SiriusXM Declares Quarterly Cash Dividend SiriusXM Declares Quarterly Cash Dividend PR Newswire NEW YORK, Oct. 22, 2025 NEW YORK, Oct. 22, 2025 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today announced...

Sirius XM (SIRI) Rises Higher Than Market: Key Facts

In the most recent trading session, Sirius XM (SIRI) closed at $21.64, indicating a +1.22% shift from the previous trading day.

Sirius XM (SIRI) Beats Stock Market Upswing: What Investors Need to Know

In the most recent trading session, Sirius XM (SIRI) closed at $21.45, indicating a +2.48% shift from the previous trading day.

Zacks Industry Outlook Highlights Fox, Sirius XM and AMC Networks

Zacks highlights FOXA, SIRI, and AMCX as top Broadcast Radio & TV stocks benefiting from rising digital content demand, streaming growth, and strong advertising strategies.

3 Broadcast Radio & TV Stocks to Buy From a Prospering Industry

Radio and television broadcast companies like FOXA, SIRI and AMCX benefit from higher content consumption and steady digital viewing despite intense competition for ad revenues.

Sirius XM (SIRI) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Sirius XM (SIRI) closed at $22.66, marking a -2.64% move from the previous day.

Sirius XM (SIRI) Declines More Than Market: Some Information for Investors

Sirius XM (SIRI) closed the most recent trading day at $22.58, moving 2.04% from the previous trading session.

Sirius XM (SIRI) Outperforms Broader Market: What You Need to Know

In the closing of the recent trading day, Sirius XM (SIRI) stood at $24.43, denoting a +1.54% move from the preceding trading day.

U.S. President Donald Trump on Wednesday said radio personality Howard Stern may have lost his job at SiriusXM because he's not a Trump supporter and backed Hillary Clinton in the 2016 presidential race.Interestingly,&nbsp;neither Stern&nbsp;nor SiriusXM&nbsp;(SIRI)&nbsp;has confirmed the cancellation of "The Howard Stern Show," and Trump was responding after a reporter presented the rumours as a confirmed development."Howard Stern is a name I haven't heard. I used to do his show. We used to have fun, but I haven't heard that name in a long time. What happened? He got terminated?" Trump said in a briefing, a video of which was&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/RapidResponse47/status/1953212648738160706">shared</a> on the White House's Rapid Response account.The reporter responded that Stern and SiriusXM were parting ways over&nbsp;differences in salary."You know when he went down? When he endorsed Hillary Clinton, he lost his audience. People said, 'Give me a break.' He went down when he endorsed Hillary Clinton," Trump replied.Recently, Trump has become increasingly vocal about media personalities who have been critical of him or have not openly supported him.On social media and in his interviews, Trump has targeted primetime personalities Jimmy Kimmel and Jimmy Fallon, who host "Jimmy Kimmel Live" on ABC and "The Tonight Show" on NBC, respectively, as well as "CBS Mornings" Co-Host Gayle King.On Wednesday, Trump continued his verbal attacks. "Colbert has no talent. I mean, I could take anybody here, I could go outside on the beautiful streets and pick a couple of people that would do just as well or better," he said.&nbsp;"Fallon has no talent. Kimmel has no talent. They're next. They're going to be going. I hear they are going to be going. I don't know, but I would imagine, because Colbert has better ratings than Kimmel or Fallon.""The Howard Stern Show," which first aired on Sirius XM in 2006, has attracted attention and controversy for its uncensored humor and commentary, bold interviews, and taboo topics. Stern has reportedly criticized Trump's handling of the COVID-19 pandemic, his behavior during the&nbsp;Jan. 6 Capitol riots, and what Stern saw as a lack of concern for public welfare and truth.Trump's comments come amid rumours of SiriusXM considering axing his show. "Stern's contract is up in the fall, and while Sirius is planning to make him an offer, they don't intend for him to take it," the US Sun reported on Tuesday, citing an insider.According to The Fly, Benchmark said that there would be "nil effect" on SiriusXM's operating results and share price if Stern departs. Stern had signed a five-year contract in 2020, reportedly for $500 million.&nbsp;The research firm reiterated its 'Buy' rating on SiriusXM, with a $28 price target, noting that the company will remain the exclusive home of Stern, as it owns both audio and video rights to his show.&nbsp;The firm downplayed any future drama around contract renewals, calling such negotiations "implausible." Benchmark also highlighted SiriusXM's continued appeal in the current audio landscape, citing shows from high-profile personalities such as Stephen A. Smith and Alex Cooper.<a href="https://stocktwits.com/symbol/SIRI">SiriusXM’s stock</a> is down more than 8% this year, with retail sentiment on Stocktwits last reading ‘bullish’ for the ticker.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/airbnb-stock-falls-after-hours-on-soft-outlook-retail-cheers-strong-q2-travel-rebound-commentary/chrlYiRRd5M">Airbnb Stock Falls After-Hours On Soft Outlook: Retail Cheers Strong Q2, Travel Rebound Commentary</a>

Howard Stern is seen arriving to the ABC studio for GMA on May 09, 2019 in New York City. (Photo by Gilbert Carrasquillo/GC Images)

Trump Takes Aim At Next Talk Show Star — Says SiriusXM’s Howard Stern ‘Went Down’ After Backing Hillary Clinton in 2016

"The Howard Stern Show," which first aired on Sirius XM in 2006, has over the years attracted attention and controversy for its uncensored humor and commentary, bold interviews, and taboo topics.

Equity

"The Howard Stern Show," which first aired on Sirius XM in 2006, has over the years attracted attention and controversy for its uncensored humor and commentary, bold interviews, and taboo topics.


SiriusXM Holdings, Inc. engages in the provision of audio entertainment. It operates through Sirius XM and Pandora and Off-Platform segments. The company was founded on May 17, 1990, and is headquartered in New York, NY.

Sirius XM Holdings Inc.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

SIRI
Sirius XM Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SIRI News

SIRISirius XM Holdings Inc